Latest papers

Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.

Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway.

Direct analysis of polyols using 3-nitrophenylboronic acid in capillary electrophoresis: thermodynamic and electrokinetic principles of molecular recognition.

Multigene expression-based predictors for sensitivity to Vorinostat and Velcade in non-small cell lung cancer.

Stereoselective synthesis of vinyl-substituted (Z)-stilbenes by rhodium-catalysed addition of arylboronic acids to allenic alcohols.

Complete response obtained by bortezomib plus dexamethasone in a patient with relapsed multiple myeloma with multiple plasmacytomas.

Reassessing the standard of care in indolent lymphoma: a clinical update to improve clinical practice.

Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access.

Regulation of autophagy by ATF4 in response to severe hypoxia.

A recyclable Au(I) catalyst for selective homocoupling of arylboronic acids: significant enhancement of nano-surface binding for stability and catalytic activity.

Proteomics of apoptosis of multiple myeloma cells induced by proteasome inhibitor PS-341.

First-line treatment of elderly multiple myeloma patients.

Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortium.

The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro.

Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines.

Facile synthesis of palladium nanoparticles with high chemical activity using cucurbit[6]uril as protecting agent.

Modern proteomic methodologies for the characterization of lactosylation protein targets in milk.

An alkynylboronate cycloaddition strategy to functionalised benzyne derivatives.

Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.

Effect of noncompetitive proteasome inhibition on bortezomib resistance.